End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,629 MXN | +1.22% | -.--% | -.--% |
07-05 | Sector Update: Health Care Stocks Steady Premarket Friday | MT |
07-05 | Sector Update: Health Care | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's high margin levels account for strong profits.
- The company is in a robust financial situation considering its net cash and margin position.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 123B | - | ||
+56.89% | 823B | C+ | ||
+39.52% | 627B | B | ||
-6.55% | 353B | C+ | ||
+7.92% | 295B | C+ | ||
+13.74% | 239B | B+ | ||
+13.83% | 220B | B- | ||
-0.49% | 219B | A+ | ||
+7.94% | 167B | C+ | ||
-2.57% | 159B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SAN Stock
- SAN1 N Stock
- Ratings Sanofi